Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FY8PQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $131,736
Award facts
- Contract value 100% obligated
- $131,736.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $131,736.22 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml pen injectors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 1, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other allergic and inflammatory conditions, making this delivery order part of the Defense Health System's pharmaceutical procurement operations.
This delivery order operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capacity to fulfill complex medical supply requirements through open competition and its established position as a primary pharmaceutical supplier within the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FY8PQ?
SPE2DB25FY8PQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FY8PQ worth?
The government has obligated $131,736 on SPE2DB25FY8PQ.
Is contract SPE2DB25FY8PQ an order under another contract?
Yes. SPE2DB25FY8PQ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8PQ competed?
The extent of competition for SPE2DB25FY8PQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award